Tag: DAWN Trial

Stryker Announces an Early Stop to Enrollment in the DAWN™ Trial Due to the High Probability of Trial Success

KALAMAZOO, MICHIGAN (PRWEB) MARCH 08, 2017 Stryker announced an early end to patient enrollment in the DAWN Trial, a clinical study designed to compare mechanical thrombectomy with the Trevo® Retriever plus medical therapy against medical therapy alone when initiated within six to 24 hours after time last known well. The […]